Germany – Technical inspection and testing services – Rahmenverträge zur Beauftragung von DGUV V3 Prüfungen

Health Services · Germany government procurement

Closed October 30, 2025. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

Vitos is the largest provider of mental health care in Hesse. The company operates psychiatric, psychosomatic, and forensic psychiatric clinics, as well as psychiatric rehabilitation facilities. Its accompanying psychiatric services are geared towards people with chronic mental illnesses. In addition to its core mission of diagnosing and treating mental illnesses, Vitos also operates a specialized neurological clinic in Weilmünster, an orthopedic clinic in Kassel, and facilities for youth and disability services throughout Hesse. Vitos is a subsidiary of the Hessian State Welfare Association (LWV). The group, headquartered in Kassel, comprises 18 non-profit organizations. 12,200 employees at 115 locations generate annual revenue of one billion euros. They provide inpatient and day-patient treatment to a total of 44,000 patients and deliver 300,000 outpatient treatments annually. For further information, please refer to the Vitos Group website at www.vitos.de. The subject of this tender procedure is the conclusion of a framework agreement governing the regular testing of electrical equipment in accordance with DGUV V3. The services are to be provided in accordance with the specifications described in the tender documents. The service will be awarded in lots. During the term of the agreement, individual orders may be placed by the eligible companies and the contracting authority. The direct contracting parties will be Vitos gGmbH and the bidder awarded the contract for the respective lot. The respective eligible company is the direct debtor of the contractor for the services rendered to the eligible companies. The contract has a term of two years. The contracting authority has the right to extend the contract for a further two years if it notifies the contractor of this in writing six months before the contract expires. The framework agreement terminates prematurely for each lot as soon as the maximum number of equipment tests agreed for the respective lot has been...

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyHealth Services
CountryGermany
CategoryArchitecture and Engineering
CPV71630000
PublishedSeptember 29, 2025
Procurement stageActive solicitation
ClosedOctober 30, 2025
StatusClosed — no longer accepting responses
TranslationTranslated from Hungarian by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Browse Similar Open Opportunities in Germany

Germany – Engineering services – Conclusion of a non-exclusive framework agreement for control tests and further building material investigations in the open-house procedure of the Thuringian State Office for Construction and Transport, published 2025
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu patentgeschützten Wirkstoffen-VV88
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Erythropoietin zeta, ATC B03AX01
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Baumpollen, ATC V01AA05
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Nilotinib (ATC: L01EA03)
Germany – Pharmaceutical products – Arzneimittel mit der Wirkstoffkombination Timolol und Tafluprost (ATC: S01ED70)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Eisen (parenterale Zubereitungen), ATC B03AC07 f. d. Z. 01.11.25-31.10.27 (zzgl.Verlängerungsoption 1x12 Mon)
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Formoterol, Glycopyrroniumbromid und Budesonid , ATC R03AL11

See every Germany Architecture and Engineering opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Architecture and Engineering intelligence report in your inbox

A personalized report on Germany Architecture and Engineering opportunities, emailed in 5-10 minutes. One per month, no account needed.